Physiomics (PYC) Share Price, News & Analysis

Company Overview

Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford, the United Kingdom.

Key Stats

• Today's Range: 0.80 to 1.25
• 50-Day Range: 0.65 to 0.99
• 52-Week Range: 0.60 to 1.76
• Volume: 21.07 million shs
• Average Volume: 8.01 million shs
• Market Capitalization: £2.13 million
• P/E Ratio: N/A
• Dividend Yield: 6.20%
• Price Target: N/A
• Consensus Rating: N/A

PYC Stock Analysis - Frequently Asked Questions

How have PYC shares performed this year?

Physiomics' stock was trading at GBX 0.78 at the beginning of the year. Since then, PYC stock has increased by 38.7% and is now trading at GBX 1.08.
View the best growth stocks for 2025 here.

How were Physiomics' earnings last quarter?

Physiomics Plc (LON:PYC) posted its quarterly earnings results on Wednesday, September, 30th. The company reported ($0.09) earnings per share for the quarter. Physiomics had a negative net margin of 106.80% and a negative trailing twelve-month return on equity of 149.67%.

How do I buy shares of Physiomics?

Shares of PYC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Physiomics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Physiomics investors own include Andalas Energy and Power (ADL), Tavistock Investments (TAVI), Parsley Box Group (MEAL), Uranium Energy (UEC), Tiziana Life Sciences (TLSA), IGas Energy (IGAS) and Hertz Global (HTZ).

Company Calendar

• Last Earnings: 9/30/2020
• Today: 1/21/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: LON:PYC
• CUSIP: N/A
• CIK: N/A
• Web: www.physiomics-plc.com
• Phone: +44-1865-784980
• Fax: N/A
• Employees: 10
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: -106.80%
• Pretax Margin: N/A
• Return on Equity: -149.67%
• Return on Assets: -76.38%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.87
• Quick Ratio: 6.48

Sales & Book Value

• Annual Sales: £900,707.00
• Price / Sales: 1.87
• Cash Flow: GBX 0.20 per share
• Price / Cash Flow: 4.21
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 203,210,000
• Free Float: N/A
• Market Cap: £1.69 million
• Optionable: Not Optionable
• Beta: 1.69